This time last year, Croda Pharma and Botanical Solution Inc (BSI) announced that they’d entered into a strategic collaboration agreement to support the sustainable sourcing of pharmaceutical ...
Berenberg Bank analyst Richard Hatch maintained a Buy rating on Croda International (CRDA – Research Report) yesterday and set a price target of £38.00. The company’s shares closed yesterday ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback